RE: Some good news today....23 Apr 2024 17:46
A CLX timeline:
24 October 22 - Subsidiary launched
06 December 2022 - already commenced a full preclinical development
31 March 2023 - no immediate toxicology concerns
28 September 2023 - Opportunities for early partnering are being explored for Cytolytix, with active commercial development to promote the project to potential industry partners
Hardly, quick.
I couldn't even tell you where this asset is up to now, as the progress appears to be going backwards based on the last quarterly update. Unless the statement about early partnering was a bit of a fib ;-)
You keep giving the excuses though, eh!